PMV Pharmaceuticals (PMVP) Short Interest
Nasdaq • PMVP • US69353Y1038
As of Oct 27, 2026, ORTEX estimated 3.9% of free float sold short, 2.8 days to cover, cost to borrow 1.48%. Sign up for live short interest data.
Nasdaq • PMVP • US69353Y1038
As of Oct 27, 2026, ORTEX estimated 3.9% of free float sold short, 2.8 days to cover, cost to borrow 1.48%. Sign up for live short interest data.
This page tracks how heavily PMV Pharmaceuticals (Nasdaq:PMVP) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
PMV Pharmaceuticals (Nasdaq: PMVP) has a market capitalization of $92.13M. Last close $1.22 (as of 2026-11-11); 52-week range $1.02 to $1.91. ORTEX data as of 2026-10-27: short interest was 3.87% of free float, 2.8 days to cover and the average cost to borrow was 1.48%. Sign up for live short interest data.